Discovery of predictive biomarkers in malignant gliomas

由 Holdhoff, Matthias
發表在 Neuro Oncol (2019)

Controversies in the Adjuvant Therapy of High-Grade Gliomas

由 Holdhoff, Matthias, Grossman, Stuart A.
出版 2011

Emerging methods for disease monitoring in malignant gliomas

由 Ambady, Prakash, Bettegowda, Chetan, Holdhoff, Matthias
發表在 CNS Oncol (2013)

Glioblastoma in older adults

由 Holdhoff, Matthias, Rothenberger, Raphael, Browner, Ilene E.
發表在 Aging (Albany NY) (2018)

Systemic Approach to Recurrent Primary CNS Lymphoma: Perspective on Current and Emerging Treatment Strategies

由 Holdhoff, Matthias, Wagner-Johnston, Nina, Roschewski, Mark
發表在 Onco Targets Ther (2020)

Actionable molecular biomarkers in primary brain tumors

由 Staedtke, Verena, Dzaye, Omar Dildar a, Holdhoff, Matthias
發表在 Trends Cancer (2016)

Systemic use of tumor necrosis factor alpha as an anticancer agent

由 Roberts, Nicholas J., Zhou, Shibin, Diaz, Luis A., Holdhoff, Matthias
出版 2011

Blood-based biomarkers for malignant gliomas

由 Holdhoff, Matthias, Yovino, Susannah G., Boadu, Osei, Grossman, Stuart A.
出版 2013

Persistent Positron Emission Tomography–Positive Liver Lesions After Successful Chemotherapy in Mediastinal Seminoma

由 Holdhoff, Matthias, Wung, Peter K., Petronis, John D., Couzi, Rima
出版 2007

‘Elderly’ patients with newly diagnosed glioblastoma deserve optimal care

由 Holdhoff, Matthias, Rosner, Gary L., Alcorn, Sara, Grossman, Stuart A.
出版 2013

PATH-35. FREQUENCY AND CHARACTERISTICS OF H3K27M-MUTATION IN ADULTS WITH RADIOGRAPHICALLY-DETERMINED MIDLINE GLIOMAS

由 Schreck, Karisa, Ranjan, Surabhi, Skorupan, Nebojsa, Ames, Heather, Holdhoff, Matthias
發表在 Neuro Oncol (2018)

Late relapses in primary CNS lymphoma after complete remissions with high-dose methotrexate monotherapy

由 Ambady, Prakash, Holdhoff, Matthias, Bonekamp, David, Wong, Fay, Grossman, Stuart A
發表在 CNS Oncol (2015)

HOUT-22. PATTERN OF BEVACIZUMAB USE IN PATIENTS WITH GLIOBLASTOMA AT NATIONAL CANCER INSTITUTE-DESIGNATED CANCER CENTERS IN 2017

由 Ranjan, Surabhi, Skorupan, Nebojsa, Ye, Xiaobu, Yankulina, Olga, Grossman, Stuart A, Holdhoff, Matthias
發表在 Neuro Oncol (2017)

INNV-28. TEMOZOLOMIDE IN RENAL DYSFUNCTION

由 Garzio, Kayla, McElroy, Kelly, Grossman, Stuart, Holdhoff, Matthias, Ozer, Byram, Yankulina, Olga
發表在 Neuro Oncol (2020)

AT-27 CHALLENGES OF RETROSPECTIVELY DETERMINING THE EQUIVALENCE OF PCV VERSUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED 1p/19q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMAS

由 Jain, Rohit, Abdelaziz, Ahmed, Blakeley, Jaishri O., Ye, Xiaobu, Grossman, Stuart A., Holdhoff, Matthias
出版 2014

Ipilimumab-Induced Enteritis without Colitis: A New Challenge

由 Messmer, Marcus, Upreti, Sunita, Tarabishy, Yaman, Mazumder, Nikhilesh, Chowdhury, Reezwana, Yarchoan, Mark, Holdhoff, Matthias
發表在 Case Rep Oncol (2016)

Pneumocystis jirovecii prophylaxis in patients treated for high-grade gliomas: a survey among neuro-oncologists

由 Skorupan, Nebojša, Ranjan, Surabhi, Mehta, Seema, Yankulina, Olga, Nenortas, Nathan, Grossman, Stuart, Ye, Xiaobu, Holdhoff, Matthias
發表在 Neurooncol Pract (2019)

ACTR-63. PHASE I DOSE ESCALATION STUDY OF PROCASPASE ACTIVATING COMPOUND-1 (PAC-1) IN COMBINATION WITH TEMOZOLOMIDE IN PATIENTS WITH RECURRENT ANAPLASTIC ASTROCYTOMA OR GLIOBLASTOM...

由 Holdhoff, Matthias, Nicholas, Martin, Peterson, Richard, Danciu, Oana, Maraka, Stefania, Hergenrother, Paul, Tarasow, Theodore, Dudek, Arkadiusz
發表在 Neuro Oncol (2019)

High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma

由 Holdhoff, Matthias, Ambady, Prakash, Abdelaziz, Ahmed, Sarai, Guneet, Bonekamp, David, Blakeley, Jaishri, Grossman, Stuart A., Ye, Xiaobu
出版 2014

ACTR-06. INITIAL RESULTS OF A PHASE I STUDY OF PROCASPASE ACTIVATING CCOMPOUND-1 (PAC-1) IN COMBINATION WITH TEMOZOLOMIDE FOR RECURRENT MALIGNANT GLIOMA

由 Nicholas, Martin, Holdhoff, Matthias, Peterson, Richard, Danciu, Oana, Wefel, Jeffrey, Tarasow, Ted, Hergenrother, Paul J, Dudek, Arkadiussz
發表在 Neuro Oncol (2018)